Long-Term Positives En-Route, Review of Healthcare Reform - Equity Research on Achillion Pharmaceuticals, Inc. and Health Management Associates, Inc.
(firmenpresse) - HONG KONG -- (Marketwire) -- 07/22/11 -- Today, released its industry report highlighting Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and Health Management Associates, Inc. (NYSE: HMA). Full fundamental and technical analysis is available at .
While it is thought that the recent health care reform legislation will negatively affect industry profitability over the next few years, it has seen eventual benefits accruing from significant expansion of the market, with new coverage potentially being provided to 32 million currently uninsured Americans. Firms with well-defined growth prospects and generous dividend yields should hold their ground and perform relatively well over the coming quarters.
World Street Fundamentals has highlighted Achillion Pharmaceuticals, Inc. as a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, the Company focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections. As of December 31, 2009, Achillion focused on developing three Hepatitis C virus (HCV) drug candidates: ACH-1625, a protease inhibitor for the treatment of chronic hepatitis C in phase Ib clinical testing; ACH-1095, a NS4A antagonist also for the treatment of chronic hepatitis C, in late stage preclinical testing, and ACH-2684, a high-potency protease inhibitor in preclinical testing. The entire report on Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is available here: .
World Street has featured Health Management Associates, Inc. as an operator of general acute care hospitals in non-urban communities. As of December 31, 2010, the Company operated 59 hospitals with a total of 8,864 beds in Alabama, Arkansas, Florida, Georgia, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Washington and West Virginia. Services provided by the Company's hospitals include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care and pediatric services. The entire report on Health Management Associates, Inc. (NYSE: HMA) is available here: .
About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets. Covering the top performers in the hottest sectors and providing clarity to investors around the world.
Contact:
Adam Redford
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.07.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 37021
Anzahl Zeichen: 0
contact information:
Town:
HONG KONG
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 199 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Long-Term Positives En-Route, Review of Healthcare Reform - Equity Research on Achillion Pharmaceuticals, Inc. and Health Management Associates, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
World Street Fundamentals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
